John Marken

2.0k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

John Marken is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, John Marken has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in John Marken's work include Monoclonal and Polyclonal Antibodies Research (7 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (5 papers). John Marken is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (5 papers). John Marken collaborates with scholars based in United States, Germany and China. John Marken's co-authors include Henrik Clausen, Sen-itiroh Hakomori, Fumiichiro Yamamoto, Thayer White, Heather MacPherson, L. Hovy, Dirk Anderson, Stuart H. Ralston, Michael P. Whyte and Christine Bell and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Genetics.

In The Last Decade

John Marken

13 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular genetic basis of the histo-blood group ABO system

1990 869 citations Fumiichiro Yamamoto, Henrik Clausen et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Marken United States	9	607	587	387	294	280	13	1.5k
Yu-Chung Yang United States	18	860 1.4×	316 0.5×	167 0.4×	320 1.1×	488 1.7×	21	1.6k
Serge Fichelson France	29	1.2k 2.0×	1.1k 1.9×	239 0.6×	339 1.2×	482 1.7×	65	2.5k
Shin‐ichiro Takayanagi Japan	14	634 1.0×	617 1.1×	124 0.3×	553 1.9×	635 2.3×	29	1.6k
W. David Hankins United States	21	564 0.9×	584 1.0×	367 0.9×	260 0.9×	306 1.1×	57	1.5k
Kathryn A. Kolquist United States	12	634 1.0×	188 0.3×	271 0.7×	467 1.6×	449 1.6×	20	1.5k
Jill Giles‐Komar United States	17	349 0.6×	163 0.3×	232 0.6×	164 0.6×	632 2.3×	30	1.3k
JR Keller United States	23	890 1.5×	981 1.7×	273 0.7×	603 2.1×	1.3k 4.6×	42	2.7k
T. Venkat Gopal United States	11	811 1.3×	296 0.5×	127 0.3×	210 0.7×	873 3.1×	15	2.1k
DA Williams United States	16	575 0.9×	460 0.8×	111 0.3×	444 1.5×	599 2.1×	37	1.5k
Dominique Bories France	18	506 0.8×	709 1.2×	60 0.2×	194 0.7×	404 1.4×	33	1.5k

Countries citing papers authored by John Marken

Since Specialization

Citations

This map shows the geographic impact of John Marken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Marken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Marken more than expected).

Fields of papers citing papers by John Marken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Marken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Marken. The network helps show where John Marken may publish in the future.

Co-authorship network of co-authors of John Marken

This figure shows the co-authorship network connecting the top 25 collaborators of John Marken. A scholar is included among the top collaborators of John Marken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Marken. John Marken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Wang, Ting, et al.. (2022). Immune complex–driven neutrophil activation and BAFF release: a link to B cell responses in SLE. Lupus Science & Medicine. 9(1). e000709–e000709. 9 indexed citations

2.

Marken, John, Sujatha Muralidharan, & Natalia V. Giltiay. (2021). Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients. Arthritis Research & Therapy. 23(1). 5–5. 15 indexed citations

3.

Marken, John, Sujatha Muralidharan, & Natalia V. Giltiay. (2021). Correction to: Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients. Arthritis Research & Therapy. 23(1). 36–36. 1 indexed citations

4.

Wang, Ting, John Marken, Janice Chen, et al.. (2019). High TLR7 Expression Drives the Expansion of CD19+CD24hiCD38hi Transitional B Cells and Autoantibody Production in SLE Patients. Frontiers in Immunology. 10. 1243–1243. 57 indexed citations

5.

Giltiay, Natalia V., Geraldine Shu, Ting Wang, et al.. (2016). TLR7 responsiveness of human transitional B cells. The Journal of Immunology. 196(1_Supplement). 124.17–124.17. 2 indexed citations

6.

Martinez, Refugio A., Jason L. Stein, Angelique M. Nelson, et al.. (2015). Genome engineering of isogenic human ES cells to model autism disorders. Nucleic Acids Research. 43(10). e65–e65. 14 indexed citations

7.

Scalley‐Kim, Michelle, Bruce W. Hess, Ryan L. Kelly, et al.. (2012). A Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation. PLoS ONE. 7(8). e43332–e43332. 6 indexed citations

8.

Hughes, Anne E., Stuart H. Ralston, John Marken, et al.. (2000). Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nature Genetics. 24(1). 45–48. 353 indexed citations

9.

Bajorath, Jürgen, John Marken, N. Jan Chalupny, et al.. (1995). Analysis of gp39/CD40 Interactions Using Molecular Models and Site-Directed Mutagenesis. Biochemistry. 34(31). 9884–9892. 53 indexed citations

10.

Edwards, Caroline P., et al.. (1995). Cloning of the Murine Counterpart of the Tumor-Associated Antigen H-L6: Epitope Mapping of the Human and Murine L6 Antigens. Biochemistry. 34(39). 12653–12660. 6 indexed citations

11.

Chalupny, N. Jan, John Marken, Anthony W. Siadak, et al.. (1995). Identification of Residues on CD40 and Its Ligand Which Are Critical for the Receptor-Ligand Interaction. Biochemistry. 34(6). 1833–1844. 66 indexed citations

12.

Maresh, Grace A., John Marken, Michael Neubauer, et al.. (1994). Cloning and Expression of the Gene for the Melanoma-Associated ME20 Antigen. DNA and Cell Biology. 13(2). 87–95. 22 indexed citations

13.

Yamamoto, Fumiichiro, Henrik Clausen, Thayer White, John Marken, & Sen-itiroh Hakomori. (1990). Molecular genetic basis of the histo-blood group ABO system. Nature. 345(6272). 229–233. 869 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact